Sanuwave Shares Tumble on 2Q Revenue Outlook Cut

Dow Jones

Jun 16

By Dean Seal

Shares of Sanuwave Health sank after the company cut its revenue guidance for the current quarter.

The stock dropped 37% to $9.22 in early trading. Shares have fallen 68% since the year started.

The medical device maker said before the opening bell that it now expects $8.5 million to $9.5 million in revenue for the fiscal second quarter, instead of the $11.1 million to $11.6 million it projected in May.

Chief Executive Morgan Frank said there have been material changes in the conditions of the capital equipment market for Sanuwave's UltraMIST system, which uses low-frequency ultrasound in a saline mist to help heal wounds. Signs of improvement in March and April reversed in May and early June, Frank said.

"Widespread clawbacks of CMS reimbursement for skin sub and allograft usage have been coming in far worse than many seem to have expected," Frank said. "This has been driving a number of wound care practices out of business."

Some of those closures have resulted in used UltraMIST systems going up for sale, siphoning away demand for new systems, according to Frank.

Write to Dean Seal at dean.seal@wsj.com

(END) Dow Jones Newswires

June 16, 2026 10:13 ET (14:13 GMT)

Copyright (c) 2026 Dow Jones & Company, Inc.

At the request of the copyright holder, you need to log in to view this content

LOGIN / SIGN UP

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

1
2
3
4
5
6
7
8
9
10

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.gotigerhk.com/news/2643768096"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2643768096\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2643768096?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-06-16 22:13","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2643768096","market":"other","top_or_hot":-1,"title":"Sanuwave Shares Tumble on 2Q Revenue Outlook Cut","media":"Dow Jones","content":"<font class=\"NormalMinus1\" face=\"Arial\">\n<p>\n  By Dean Seal \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  Shares of Sanuwave Health sank after the company cut its revenue guidance for the current quarter. \n</p>\n<p>\n  The stock dropped 37% to $9.22 in early trading. Shares have fallen 68% since the year started. \n</p>\n<p>\n  The medical device maker said before the opening bell that it now expects $8.5 million to $9.5 million in revenue for the fiscal second quarter, instead of the $11.1 million to $11.6 million it projected in May. \n</p>\n<p>\n  Chief Executive Morgan Frank said there have been material changes in the conditions of the capital equipment market for Sanuwave's UltraMIST system, which uses low-frequency ultrasound in a saline mist to help heal wounds. Signs of improvement in March and April reversed in May and early June, Frank said. \n</p>\n<p>\n  \"Widespread clawbacks of CMS reimbursement for skin sub and allograft usage have been coming in far worse than many seem to have expected,\" Frank said. \"This has been driving a number of wound care practices out of business.\" \n</p>\n<p>\n  Some of those closures have resulted in used UltraMIST systems going up for sale, siphoning away demand for new systems, according to Frank. \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  Write to Dean Seal at dean.seal@wsj.com \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  June 16, 2026 10:13 ET (14:13 GMT)\n</p>\n<p>\n  Copyright (c) 2026 Dow Jones &amp; Company, Inc.\n</p>\n</font>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Sanuwave Shares Tumble on 2Q Revenue Outlook Cut</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nSanuwave Shares Tumble on 2Q Revenue Outlook Cut\n</h2>\n\n<h4 class=\"meta\">\n\n\n<div class=\"head\" \">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Dow Jones </p>\n<p class=\"h-time\">2026-06-16 22:13</p>\n</div>\n\n</div>\n\n\n</h4>\n\n</header>\n<article>\n<font class=\"NormalMinus1\" face=\"Arial\">\n<p>\n  By Dean Seal \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  Shares of Sanuwave Health sank after the company cut its revenue guidance for the current quarter. \n</p>\n<p>\n  The stock dropped 37% to $9.22 in early trading. Shares have fallen 68% since the year started. \n</p>\n<p>\n  The medical device maker said before the opening bell that it now expects $8.5 million to $9.5 million in revenue for the fiscal second quarter, instead of the $11.1 million to $11.6 million it projected in May. \n</p>\n<p>\n  Chief Executive Morgan Frank said there have been material changes in the conditions of the capital equipment market for Sanuwave's UltraMIST system, which uses low-frequency ultrasound in a saline mist to help heal wounds. Signs of improvement in March and April reversed in May and early June, Frank said. \n</p>\n<p>\n  \"Widespread clawbacks of CMS reimbursement for skin sub and allograft usage have been coming in far worse than many seem to have expected,\" Frank said. \"This has been driving a number of wound care practices out of business.\" \n</p>\n<p>\n  Some of those closures have resulted in used UltraMIST systems going up for sale, siphoning away demand for new systems, according to Frank. \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  Write to Dean Seal at dean.seal@wsj.com \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  June 16, 2026 10:13 ET (14:13 GMT)\n</p>\n<p>\n  Copyright (c) 2026 Dow Jones &amp; Company, Inc.\n</p>\n</font>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4082","symbol_name":"医疗保健设备","start_time":0,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","article_id":"2643768096","we_media_id":"106","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2643768096","pubTimestamp":1781619180,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Dow Jones","introduction":"Dow Jones publishes the world’s most trusted business news and financial information in a variety of media.","home_visible":0,"id":"106","head_image":"https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99"},"summary":"Shares of Sanuwave Health sank after the company cut its revenue guidance for the current quarter.The stock dropped 37% to $9.22 in early trading. Shares have fallen 68% since the year started.The medical device maker said before the opening bell that it now expects $8.5 million to $9.5 million in revenue for the fiscal second quarter, instead of the $11.1 million to $11.6 million it projected in May.Chief Executive Morgan Frank said there have been material changes in the conditions of the capital equipment market for Sanuwave's UltraMIST system, which uses low-frequency ultrasound in a saline mist to help heal wounds. Signs of improvement in March and April reversed in May and early June, Frank said.Some of those closures have resulted in used UltraMIST systems going up for sale, siphoning away demand for new systems, according to Frank.","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK4082":"医疗保健设备","SNWV":"SANUWAVE Health, Inc."},"translate_title":"Sanuwave股价因第二季度收入前景下调而暴跌","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"SNWV":0.9},"content_text":"By Dean Seal \n\n\n \n\n\n  Shares of Sanuwave Health sank after the company cut its revenue guidance for the current quarter. \n\n\n  The stock dropped 37% to $9.22 in early trading. Shares have fallen 68% since the year started. \n\n\n  The medical device maker said before the opening bell that it now expects $8.5 million to $9.5 million in revenue for the fiscal second quarter, instead of the $11.1 million to $11.6 million it projected in May. \n\n\n  Chief Executive Morgan Frank said there have been material changes in the conditions of the capital equipment market for Sanuwave's UltraMIST system, which uses low-frequency ultrasound in a saline mist to help heal wounds. Signs of improvement in March and April reversed in May and early June, Frank said. \n\n\n  \"Widespread clawbacks of CMS reimbursement for skin sub and allograft usage have been coming in far worse than many seem to have expected,\" Frank said. \"This has been driving a number of wound care practices out of business.\" \n\n\n  Some of those closures have resulted in used UltraMIST systems going up for sale, siphoning away demand for new systems, according to Frank. \n\n\n \n\n\n  Write to Dean Seal at dean.seal@wsj.com \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  June 16, 2026 10:13 ET (14:13 GMT)\n\n\n  Copyright (c) 2026 Dow Jones & Company, Inc.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"-1","news_tag":"","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":true,"need_login_tip":false,"code":"91000000","status":"200"}}}